Recent research has shed new light on the weight loss effects of the diabetes and weight management medications Mounjaro and Zepbound. According to...
By 193cc Agency CouncilSeptember 12, 2024Recent research has illuminated the expanding potential of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound, which were initially approved for diabetes management...
By 193cc Agency CouncilSeptember 5, 2024Eli Lilly has unveiled a new program aimed at making its weight-loss drug, Zepbound, more accessible to self-pay patients by offering it at...
By 193cc Agency CouncilAugust 28, 2024Eli Lilly’s Zepbound, a weight loss drug, showed promise in treating sleep apnea in obese adults, the company announced Wednesday. Results from late-stage...
By 193cc Agency CouncilApril 18, 2024